Carina Biotech
Ray Wood is an accomplished professional with extensive experience in the biotechnology and clean technology sectors. Currently serving as the Director at Carina Biotech since June 2016, Ray leads initiatives focused on developing novel CART cell therapies for solid tumors. Ray has also acted as an Independent Director at the Victorian Clean Technology Fund since 2002, overseeing a $30 million venture fund dedicated to translating scientific discoveries into commercial applications. Additionally, Ray holds the position of Director Principal at Irendos Pty Ltd, providing consulting services in technology transfer and startups. Ray was the Chairperson of Cure Cell NFP from August 2020 to January 2024, working to support PhD students in cell therapy. Previously, Ray served as a Non-Executive Director at the CRC for Cell Therapy Manufacturing and co-founded Cell Therapies Pty Ltd, a specialist contract manufacturer in cell and tissue therapies. Ray holds an Advanced Management Diploma from the Macquarie Graduate School of Management and has completed studies at the University of Technology Sydney.
Carina Biotech
Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.